Our Archives section provides access to previously published issues, ensuring a comprehensive resource for researchers, practitioners, and educators.
Explore Past Issues
Volume 1
Issue 2 JULY– DECEMBER 2025
Volume 1 (Issue 2) JULY– DECEMBER 2025 Research Articles
Transitioning from Medication Supply to Holistic Patient Support: Advancing the Pharmacist’s Role in Coordinated Chronic Disease Care
Vol.1(2); Pages:1-9. Published on July-2025
Abstract
Recently, the pharmacy profession has changed from just supplying drugs to becoming involved in more broad forms of patient care. It was made possible by including advanced clinical education, having more pharmacists obtain their Pharm.D. degree, and setting up disease management as a proper healthcare tactic. Now that many pharmacists play larger roles among various types of health professionals, they assist patients with chronic illnesses, check medicines, provide information, and help improve their well-being. This document looks at how the duties of pharmacists change in team-based healthcare settings by observing their effects on topics like asthma, hypertension, diabetes, and hyperlipidemia. It also explains that community, ambulatory, and industrybased pharmacists are changing their role by collaborating, using proven treatments, and measuring the effects on people’s health.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Pharmacist-Led Medication Reconciliation at Discharge: Effects on Readmission Rate in the Older Adults with Polypharmacy
Vol.1(2); Pages:10-18. Published on August-2025
Abstract
This was a prospective interventional study that had assessed the effects of pharmacist-driven medication reconciliation on newer pediatric patients on the rate of hospital readmission within 30 days in patients with polypharmacy aged 65 and above. One hundred and sixty patients (aged 65 years or more, who were taking 5 or more medications) were randomly allocated to either the intervention group (pharmacist reconciliation) or control group (usual care). Pharmacists responded to discharge prescriptions, reached out to community providers and counseled patients and care givers. Medication discrepancies identified 58 percent of the intervention patients and cleared before the discharge. The rate of 30-days readmission was also substantially lower in the intervention group (12.5 percent) as opposed to in the control group (26.2 percent, p = 0.018). Also, the percentage of patient satisfaction and medication adherence was larger in the intervention group. The findings indicate the positive influence of pharmacist-based initiatives in transitional care models to minimise the number of readmissions and address medication security following the outward experience.
View Full PDF
Please LOGIN to View Full PDF or Read more.
A Multi-Centre Study to Integrate Clinical Pharmacists into Primary Care as a Form of Chronic Disease Management
Vol.1(2); Pages:19-29. Published on September-2025
Abstract
This multi-center implementation study was aimed at assessing the effect of implementing clinical pharmacists in primary care teams as part of managing chronic diseases (diabetes, hypertension, and dyslipidemia). Its total enrollment was 300 patients spread over six primary care clinics in Ghana and Cyprus who were tracked over a period of 6 months. Pharmacists did some medication therapy management (MTM) activities, tracked lab values, titrated medication, and collaborated with physicians. The intervention showed very good results in HbA1c (-1.2 percent), systolic blood pressure (-11.4 mmHg), and LDL-cholesterol (-18.7 mg/dL) (p < 0.01.). The performance of patient compliance improved by 22 percent, and physician satisfaction with the pharmacist cooperation was great. Such results point to the potential of incorporating pharmacists into primary care as a practice to enhance chronic disease management and outcomes in resource-scarce environments.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Pharmaceutical interventions in telehealth-based transitional care: comparative evaluation of outcome of patients in urban and rural settings
Vol.1(2); Pages:30-39. Published on October-2025
Abstract
This prospective cohort trial assessed how much transitional care undertaken by pharmacist-led telehealth helps urban and the rural patients. One hundred and eighty (recovered) patients fitted on internal medicine wards (90 urban and 90 rural) were followed up at a length of 30 days. Under telehealth, pharmacists performed medication reconciliation, and medication adherence monitoring, and remote counseling. Findings indicated a drop of 36 percent in pharmacist disparities, and a 40 percent decrease in unnecessary readmissions of the rural patients with the assistance of the pharmacist. The same was observed with urban patients. The satisfaction of patients increased above 90 percent among both groups. These results validate the idea that telepharmacy models driven by pharmacists are very beneficial in improving transitional care as well as better management of medications and equitable provision of healthcare among both urban and rural patients.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Multinational, prospective study on transitional pharmacist’s role in postoperative pain management: same-day surgery institutions
Vol.1(2); Pages:40-49. Published on November-2025
Abstract
In this multinational, prospective interventional study, the effects of the involvement of pharmacists in pharmaceutical supervision of postoperative pain management of patients who had undergone same-day surgeries in two tertiary care hospitals in Brazil and Japan were examined. The research involved 160 patients subject to orthopedic and general surgeries, with their clinical pharmacists offering individual discharge instructions, arranging the pain medications schedule, and calling the patient on days 1, 3, and 7 following the discharge. The outcomes revealed a significant reduction (p < 0.01) of the pain scale of the intervention group at 72 hours after the surgery, fewer unplanned emergency visits (4.3% vs 12.5%) and a higher level of analgesics prescription compliance in the intervention group compared to the control one. Such findings emphasize the necessity of the pharmacists in transitional pain care, recommending their inclusion in discharge programs of outpatient surgery in order to adequately manage pain to minimize complications.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Issue 1 JANUARY- JUNE 2025
Volume 1(Issue 1) JANUARY- JUNE 2025 Research Articles
Enhancing Basic Science Education in Pharmacy Through the Use of Forensic Case Studies
Vol.1(1); Pages:1-9. Published on June-2025
Abstract
Between two-thirds and three-fourths of all pharmacy schools fail to teach forensic pharmacy, a profession where pharmacists support investigators. Therefore, a new educational activity was introduced to enhance the teaching of basic science to first-year pharmacy students. This summer program relied on episodes of Forensic Files to allow students to learn about the work of forensic pharmacists and gain more knowledge about pharmacology, toxicology, pharmacokinetics, and medicinal chemistry. I organized students into different groups to analyze the episodes they were assigned. I also had them provide reports about the incident and deliver presentations on the safety problems and how medications were part of the story. Most of the participants reported that their knowledge of basic sciences, team spirit, self-learning, and critical thinking were all better as a result of this activity. Employing real criminal cases matched Bloom’s taxonomy to promote overall learning. The use of this approach can open doors to including forensic science in the curriculum of future pharmacists.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Pharmacy AI-Powered Innovations: Improving Accuracy, Effectiveness, and Patient-Centered Clinical Care
Vol.1(1); Pages:10-17. Published on June-2025
Abstract
AI is driving major innovations in pharmacy and clinical pharmacy by improving efficiency, enhancing care quality, and increasing accuracy in processes. AI enables pharmacists to analyze, model, and automate data in order to successfully manage and effectively understand care for their patients. AI in pharmacy facilitates accurate administration of drugs, optimizes pharmacy product management, and allows for personalized medicine that takes into account both patient genetics and real-time health information. Integration of AI-driven CDSS into clinical pharmacy leads to more safe prescribing and decreased risks of patient harm as well as helping pharmacists design the most effective drug combination for patients. AI technology can help monitor adherence to medications, identify adverse drug reactions earlier, and better assess risks associated with drugs, contributing to higher standards of primary health care. AI-empowered pharmacists are leading the switch to healthcare that emphasizes predictive, preventive, and personalized approaches to treating patients. Challenges such as ethical and legal issues and access to rich data has become more prominent with AI integration in pharmacy. The paper demonstrates how AI is revolutionizing both pharmacy and clinical pharmacy practice as it promotes advances in personalized care, strengthens operational efficiency, and ensures patients receive complete medical assistance.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Using Ideas from Marxist Sociology to Make Social Awareness Better in Research Related to Pharmacy Practice
Vol.1(1); Pages:18-25. Published on June-2025
Abstract
We examine how Marxist sociology can inform and influence pharmacy practice research. Marxist sociology casts light on the systematic factors that influence and shape pharmacy practice at multiple levels, including how professional identity is formed, the commodification of care and the distribution of power in healthcare. We argue that drawing upon a Marxist perspective can help uncover important dimensions of pharmacy practice and support the development of a more socially aware practice model.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Overview of Protozoan Parasites and Their Clinical Significance in Pharmacy
Vol.1(1); Pages:26-34. Published on June-2025
Abstract
This material looks at protozoal organisms from the viewpoint of pharmacy by highlighting information important for today’s practices and for making decisions as a clinician. The report details unicellular eukaryotic microorganisms that are major contributors to global disease and death and arranges the information by how and where the microorganisms function in the body. Summaries of Entamoeba, Giardia, Cryptosporidium, Trichomonas and Plasmodium, Toxoplasma, Leishmania and Trypanosoma explain how they live, how they cause disease and the treatments that work against them. Special attention is given to the methods required for reliable diagnosis which rely on optical microscopy, antibody tests and amplification technologies. Pharmaceutical relevance is highlighted in the manuscript through a study of the challenges caused by protozoans’ eukaryotic development, ways they can resist drugs and their reproductive behaviors. Illustrative scenarios present examples of practice in community pharmacies, healthcare facilities, pharmacy services for travelers and worldwide health projects. Combining knowledge of microbiology and clinical pharmacy gives professionals the ability to contribute in managing protozoal diseases, choosing drugs, estimating adverse effects and guiding public health interventions against major pathogens.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Enhancing Performance Evaluation Techniques in Pharmacy Education Based on Competencies
Vol.1(1); Pages:35-42. Published on June-2025
Abstract
This material looks at protozoal organisms from the viewpoint of pharmacy by highlighting information important for today’s practices and for making decisions as a clinician. The report details unicellular eukaryotic microorganisms that are major contributors to global disease and death and arranges the information by how and where the microorganisms function in the body. Summaries of Entamoeba, Giardia, Cryptosporidium, Trichomonas and Plasmodium, Toxoplasma, Leishmania and Trypanosoma explain how they live, how they cause disease and the treatments that work against them. Special attention is given to the methods required for reliable diagnosis which rely on optical microscopy, antibody tests and amplification technologies. Pharmaceutical relevance is highlighted in the manuscript through a study of the challenges caused by protozoans’ eukaryotic development, ways they can resist drugs and their reproductive behaviors. Illustrative scenarios present examples of practice in community pharmacies, healthcare facilities, pharmacy services for travelers and worldwide health projects. Combining knowledge of microbiology and clinical pharmacy gives professionals the ability to contribute in managing protozoal diseases, choosing drugs, estimating adverse effects and guiding public health interventions against major pathogens.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Stay Updated
To stay informed about the latest research and updates in the journal, consider subscribing to our newsletter or following us on social media.
